1993
DOI: 10.1172/jci116419
|View full text |Cite
|
Sign up to set email alerts
|

Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies.

Abstract: IntroductionThis study investigates the pathophysiology of mucormycosis caused by Rhizopus, which has been reported in 46 dialysis patients, while treated with deferoxamine (DFO). This drug aggravates mucormycosis, which we experimentally induced in guinea pigs and which lead to a shortened animal survival (P < 0.01).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
263
1
3

Year Published

1997
1997
2022
2022

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 307 publications
(280 citation statements)
references
References 35 publications
6
263
1
3
Order By: Relevance
“…19 A clinical example of this is the increased rate of zygomycosis among dialysis patients treated with desferrioxamine because iron bound to desferrioxamine is efficiently used as an iron source by some species of zygomycetes. 20 We saw an association between Aspergillus and iron overload, more clearly with autografts than with allografts. In allograft patients, other potentially more important variables such as acute GVHD, immunosuppression, CMV, and steroid treatment may mask any effect of iron.…”
Section: Discussionmentioning
confidence: 87%
“…19 A clinical example of this is the increased rate of zygomycosis among dialysis patients treated with desferrioxamine because iron bound to desferrioxamine is efficiently used as an iron source by some species of zygomycetes. 20 We saw an association between Aspergillus and iron overload, more clearly with autografts than with allografts. In allograft patients, other potentially more important variables such as acute GVHD, immunosuppression, CMV, and steroid treatment may mask any effect of iron.…”
Section: Discussionmentioning
confidence: 87%
“…Iron overload was also associated with fungal infection in liver transplant (5), and in hematologic malignancies (7). Interestingly, patients being treated for iron overload with desferroxamine, a siderophore made by Streptomyces, are at increased risk for mucormycosis (56). This may be explained by the observation that Rhizopus microsporus, one of the causes of mucormycosis, is able to acquire iron from the iron-chelated form of the bacterial siderophore, ferroxamine (57).…”
Section: Discussionmentioning
confidence: 99%
“…Patients with elevated available serum iron, such as DKA patients (11) or those treated with deferoxamine (an iron siderophore that provides Rhizopus with exogenous iron) (12), are uniquely predisposed to developing mucormycosis. Furthermore, the iron chelator deferasirox, which reduces available serum iron, is effective in treating experimental hematogenously disseminated mucormycosis (13).…”
Section: Grp78 Binds To Mucorales Germlings But Not Sporesmentioning
confidence: 99%